Thomas Mandl
1 – 10 of 51
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Increased risk of multiple myeloma in primary Sjögren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies
- EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies
- 2019
- Increased B-cell activating factor, interleukin-6, and interleukin-8 in induced sputum from primary Sjögren's syndrome patients
- Infections increase the risk of developing Sjögren's syndrome
- Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndrome
- Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome
- Efficacy and safety of topical and systemic medications : A systematic literature review informing the EULAR recommendations for the management of Sjögren's syndrome
- Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome
- 2018
- Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren’s syndrome without disease modifying treatment
- Epidemiology of hypocomplementaemic urticarial vasculitis (anti-C1q vasculitis)